Accelerate Diagnostics (NASDAQ:AXDX) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Accelerate Diagnostics missed estimated earnings by -44.0%, reporting an EPS of $-0.89 versus an estimate of $-0.62.
Revenue was up $55 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.11 which was followed by a 3.0% drop in the share price the next day.
Here’s a look at Accelerate Diagnostics’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.07 | -1.40 | -1.4 | -1.5 |
| EPS Actual | -1.18 | -1.31 | -1.7 | -1.5 |
| Revenue Estimate | 3.53M | 3.60M | 3.35M | 2.87M |
| Revenue Actual | 3.30M | 2.92M | 2.81M | 2.97M |
To track all earnings releases for Accelerate Diagnostics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
